New Strategy May Target Common Cancer Driver with Minimal Side Effects (IMAGE)

Weill Cornell Medicine

New Strategy May Target Common Cancer Driver with Minimal Side Effects

Caption

Photo of a glass etched, cryo-electron microscopy-based representation of the TNKS2 enzymatic domain bound to TDI-012804, the TNKS2-selective inhibitor described in this study.

Credit

Courtesy of the Dow lab

Usage Restrictions

Restricted to use by verified journalists only.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.